Buthionine sulfoxamine

Buthionine sulfoxamine
Trade Name
Orphan Indication Use as a modulator of chemotherapy for the treatment of pediatric patients with primary malignant brain tumors
USA Market Approval USA
USA Designation Date 2005-10-05 00:00:00
Sponsor USC-CHLA Institute for Pediatric Clinical Research;Childrens Hospital of Los Angeles, 4650 Sunset Blvd, MS 55;Los Angeles, California, 90027